🔥🐔 BizChicken 🐔🔥
Companies Similar to Galecto, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Amicus Therapeutics, Inc.
Galafold
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for rare diseases, with products including Galafold for Fabry disease and developing therapies for Pompe and CLN3 diseases.
Contact | About | About | Leadership | About | Leadership | About | Contact | Careers | Careers | Careers | Jobs | Careers | Directors | About | Jobs | Careers | About | About | About
Symbol: FOLD
Recent Price: $9.41
Industry: Biotechnology
CEO: Mr. Bradley L. Campbell M.B.A.
Sector: Healthcare
Employees: 500
Address: 3675 Market Street, Philadelphia, PA 19104
Phone: 215 921 7600
Leadership
- Bradley L. Campbell, President and Chief Executive Officer
- Simon Harford, Chief Financial Officer
- David Clark, Chief People Officer
- Jayne C. Gershkowitz, Chief Patient Advocate
- Sébastien Martel, Chief Business Officer
- Ellen S. Rosenberg, Chief Legal Officer
- Jeffrey P. Castelli, Chief Development Officer
- Stephen Arnold, Chief, Head of Global Rare Disease
- Julie Yu, Chief Program Officer
- Pat O’Sullivan, Chief Technical Operations Officer
- Jill Weimer, Chief Science Officer
- Patrik Florencio, Global Chief Compliance and Risk Officer
Last updated: 2024-12-31
Adicet Bio, Inc.
ADI-001
Adicet Bio, Inc. is a biotechnology company focused on discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Their lead product ADI-001 is in Phase I clinical study for non-Hodgkin's lymphoma, with additional products in development for solid tumors.
Symbol: ACET
Recent Price: $0.90
Industry: Biotechnology
CEO: Mr. Chen Schor BA, CPA, M.B.A.
Sector: Healthcare
Employees: 143
Address: 200 Clarendon Street, Boston, MA 02116
Phone: 650 503 9095
Last updated: 2024-12-31
Arcellx, Inc.
CART-dd BCMA
Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.
About | About | News | Contact | Contact | Culture | Culture | Culture | Culture | About | About | About | About | About | News
Symbol: ACLX
Recent Price: $78.35
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Sector: Healthcare
Employees: 130
Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878
Phone: 240 327 0603
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Beam Therapeutics Inc.
precision genetic medicines
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States, with a focus on conditions such as sickle cell disease, beta thalassemia, and Glycogen Storage Disease Type Ia.
About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About | About | Careers | About | Jobs | Careers
Symbol: BEAM
Recent Price: $25.28
Industry: Biotechnology
CEO: Mr. John M. Evans M.B.A.
Sector: Healthcare
Employees: 472
Address: 238 Main Street, Cambridge, MA 02142
Phone: 857 327 8775
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Galectin Therapeutics Inc.
belapectin (GR-MD-02)
Galectin Therapeutics Inc. engages in research and development of therapies for fibrotic, cancer, and other diseases, with a focus on developing galectin-3 inhibitors like belapectin.
Symbol: GALT
Recent Price: $1.10
Industry: Biotechnology
CEO: Mr. Joel Lewis
Sector: Healthcare
Employees: 14
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA 30071
Phone: 678 620 3186
Last updated: 2024-12-31
Greenwich LifeSciences, Inc.
GP2
Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.
Symbol: GLSI
Recent Price: $10.91
Industry: Biotechnology
CEO: Mr. Snehal S. Patel
Sector: Healthcare
Employees: 3
Address: Building 14, Stafford, TX 77477
Phone: 832 819 3232
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
Structure Therapeutics Inc.
GSBR-1290
Structure Therapeutics Inc. develops novel oral therapeutics for chronic diseases with unmet medical needs, focusing on conditions like type-2 diabetes, obesity, pulmonary, and cardiovascular diseases.
Careers | Careers | Careers | Careers | Careers | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: GPCR
Recent Price: $26.63
Industry: Biotechnology
CEO: Dr. Raymond C. Stevens Ph.D.
Sector: Healthcare
Employees: 136
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 628-229-9277
Last updated: 2024-12-31
Pliant Therapeutics, Inc.
PLN-74809
Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for the treatment of fibrosis and related diseases. Their lead product candidate, PLN-74809, is currently in Phase 2a trials.
Symbol: PLRX
Recent Price: $12.79
Industry: Biotechnology
CEO: Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Sector: Healthcare
Employees: 166
Address: 260 Littlefield Avenue, South San Francisco, CA 94080
Phone: 650 481 6770
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
SELLAS Life Sciences Group, Inc.
galinpepimut-S (GPS)
SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focusing on the development of novel cancer immunotherapies in the United States. Their lead product candidate, galinpepimut-S (GPS), is in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 for ovarian cancer.
Symbol: SLS
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. Angelos M. Stergiou M.D., ScD h.c.
Sector: Healthcare
Employees: 16
Address: Times Square Tower, New York, NY 10036
Phone: 646 200 5278
Last updated: 2024-12-31
Sorrento Therapeutics, Inc.
G-MAB antibody library, Sofusa drug delivery technology, ZTlido
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focusing on developing therapies for various diseases, including cancer and autoimmune diseases, using innovative antibody libraries and drug delivery systems.
Symbol: SRNE
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Henry H. Ji Ph.D.
Sector: Healthcare
Employees: 949
Address: 4955 Directors Place, San Diego, CA 92121
Phone: 858 203 4100
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
IN8bio, Inc.
INB-200, INB-100, INB-400, INB-300
IN8bio, Inc. is a clinical-stage biotechnology company focused on gamma-delta T cell therapies for cancer treatment, with lead products in clinical trials and preclinical development.
Symbol: INAB
Recent Price: $0.27
Industry: Biotechnology
CEO: Mr. Tai-Wei Ho
Sector: Healthcare
Employees: 39
Address: 350 5th Avenue, New York, NY 10118
Phone: 646 600 6438
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31